Scio Township-based Terumo Cardiovascular Systems must pay a $35 million fine and restrict sales of its medical devices after FDA investigators uncovered violations, including failure to properly investigate an incident in which a patient died.
Eating healthy on the go is a challenge requiring good planning and creative ideas and snacks are an important part of daily healthy meal plans. Keep these healthy snacks in mind when your at the grocery store then incorporate them into your healthy eating plan as snacks that will keep ...
Since our launch 10 months ago, AnnArbor.com has worked to expand our coverage area and bring you stories not just from Ann Arbor, but from surrounding communities as well. One of our top priorities is to provide you with news and information about the vibrant community of Saline. Today, we ...
Marlin Jackson has taken some ribbing from his NFL teammates over Michigan’s 8-16 record the last two years. It’s been good-natured and fun-loving, but hard to swallow nonetheless. “I don’t know where we’re headed,” Jackson said. “I don’t want to say, but I just don’t know where we’re headed. What ...
Ann Arbor-based NanoBio Corp. announced today that it's signed an agreement with United Kingdom-based pharmaceutical giant GlaxoSmithKline to license its cold sore treatment still in clinical development. The deal provides $14.5 million upfront to NanoBio in addition to royalties and payments of up to $40 million if the treatment hits specific ...
Ann Arbor-based Aastrom Biosciences is launching another Phase 2 clinical trial to study the effectiveness of its cell treatment for a disease that causes chronic heart failure. The clinical trial will examine whether Aastrom’s cardiac repair cell technology, delivered through a catheter, can treat dilated cardiomyopathy (DCM). The trial will ...
The global medical devices company that’s acquiring Ann Arbor-based HandyLab expects to leverage the opportunity to expand into new markets, executives said today. New Jersey-based Becton, Dickinson and Co., which announced Oct. 23 that it would buy University of Michigan spinoff HandyLab, is expected to finish the acquisition this month.
For most early-stage biotech companies, revenue is but a far-off dream. They rely mostly on investors’ cash or government funding until they’re advanced enough to market a drug or sign licensing deals with major pharmaceutical companies. But the global economic crisis, which has caused investors to scale back on funding ...
The sluggish production process for the swine flu vaccine illustrates the global potential of an Ann Arbor biotech company’s technology. Antiquated vaccine production technology, which is making it difficult for manufacturers to quickly produce H1N1 flu vaccines, is creating demand for a revolutionary alternative. That's where University of Michigan spinoff ...
Not too many people get the chance to start the same company twice. But Esperion Therapeutics founder Roger Newton is reaping the benefits of learning from his company’s first mistakes and successes. Newton, the Ann Arbor scientist who famously co-discovered Lipitor, the world’s top-selling drug, is cognizant that the second ...
Good nutrition runs in the Newton family. Coco Newton, the wife of Lipitor co-discoverer and Esperion Therapeutics founder Roger Newton, is pursuing her own “functional medicine” practice in the same facility as her husband. Roger Newton’s expertise in cholesterol drugs is well known, but his doctorate degree was in nutrition.Lifetime ...
By Nathan Bomey and Tina Reed, AnnArbor.comA nanotechnology partnership between the University of Michigan and Ann Arbor-based NanoBio Corp. got a $9.3 million boost today, officials said. The National Institutes of Health awarded the grant to U-M to accelerate research on a mucosal vaccine based on nanoemulsion technology, which uses ...
An Ann Arbor biomedical device company believes its emerging technology offers hope to women who are struggling to conceive through the in-vitro fertilization process. Incept BioSystems hopes to secure approval next year from the U.S. Food and Drug Administration to market technology that would help improve the success rate of ...
Ann Arbor biotech company QuatRx Pharmaceuticals is preparing to file a new drug application with the U.S. Food and Drug Administration after completing the final clinical trial for its top drug candidate. Approval of QuatRx's post-menopausal sex drug would mark a significant accomplishment matched only by a few drug companies ...
Angela J. Cesere | AnnArbor.com AnnArbor.com's partner news site MLive.com is on a quest to find the best barbecue in ......
Get the Ann Arbor RSS Feed
AnnArbor.com